Koarai, Akira http://orcid.org/0000-0001-9147-4225
Sugiura, Hisatoshi
Yamada, Mitsuhiro
Ichikawa, Tomohiro
Fujino, Naoya
Kawayama, Tomotaka
Ichinose, Masakazu
Article History
Received: 6 January 2020
Accepted: 16 April 2020
First Online: 29 April 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: AK reports grants from Novartis, personal fees for lectures from Astellas, AstraZeneca, KYORIN, Novartis, Sanofi and TAIHO, and personal fees for lectures and consulting from Boehringer Ingelheim and GlaxoSmithKline, outside the submitted work. HS reports grants from MSD and Novartis, personal fees for lectures from Astellas, KYORIN, Novartis and Sanofi, and personal fees for lectures and consulting from AstraZeneca, Boehringer Ingelheim and GlaxoSmithKline, outside the submitted work. MY reports grants from Japan Society for the Promotion of Science and Novartis, and personal fees for lectures from AstraZeneca, Meiji Seika Pharma, Novartis and DAIICHI SANKYO, outside the submitted work. TI has nothing to disclose. NF reports personal fees for lectures from AstraZeneca, outside the submitted work. TK reports grants from Novartis, and personal fees for lectures from AstraZeneca, Boehringer Ingelheim, Meiji Seika Pharma and GlaxoSmithKline, outside the submitted work. MI reports grants from Astellas, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, KYORIN and Novartis, personal fees for lectures from KYORIN, and personal fees for lectures and consulting from Astellas, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline and Novartis, outside the submitted work.